Literature DB >> 25442134

Radiation-induced cholecystitis after hepatic radioembolization: do we need to take precautionary measures?

Jip F Prince1, Andor F van den Hoven2, Maurice A A J van den Bosch2, Mattijs Elschot2, Hugo W A M de Jong2, Marnix G E H Lam2.   

Abstract

Controversy exists over the need to take precautionary measures during hepatic radioembolization to minimize the risk of radiation-induced cholecystitis. Strategies for a variety of clinical scenarios are discussed on the basis of a literature review. Precautionary measures are unnecessary in the majority of patients and should be taken only when single photon-emission computed tomography (CT; SPECT)/CT shows a significant concentration of technetium-99m macroaggregated albumin in the gallbladder wall. In this case report with quantitative SPECT analysis, it is illustrated how an adjustment of the catheter position can effectively reduce the absorbed dose of radiation delivered to the gallbladder wall by more than 90%.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25442134     DOI: 10.1016/j.jvir.2014.06.024

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  3 in total

1.  Biodistribution of 99mTc-MAA on SPECT/CT performed for 90Y radioembolization therapy planning: a pictorial review.

Authors:  J J Bailey; Y Dewaraja; D Hubers; R N Srinivasa; K A Frey
Journal:  Clin Transl Imaging       Date:  2017-09-11

Review 2.  Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know.

Authors:  Ijin Joo; Hyo-Cheol Kim; Gyoung Min Kim; Jin Chul Paeng
Journal:  Korean J Radiol       Date:  2018-02-22       Impact factor: 3.500

3.  Radioembolisation in Europe: A Survey Amongst CIRSE Members.

Authors:  Margot T M Reinders; Etienne Mees; Maciej J Powerski; Rutger C G Bruijnen; Maurice A A J van den Bosch; Marnix G E H Lam; Maarten L J Smits
Journal:  Cardiovasc Intervent Radiol       Date:  2018-05-08       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.